The cancer patient 2-derived CD4+ T cell lines that were harvested from the induction culture responded to the CDCA139-764, CDCA155-78, and LY6K172-191 peptides in an HLA-DQ or HLA-DR-restricted manner (Fig 7B). This evidence concerns the gene CD4 and cancer.